Apple was forced to change its App Store policies to allow developers to link users to external websites for payments. This ...

Motilal Oswal recommended Neutral rating on Alembic Pharma with a target price of Rs 930 in its research report dated May 06, ...

Paytm shares surged over 8 percent on May 7 after the fintech company reported that its net loss has narrowed to Rs 540 crore ...

This agreement sets a benchmark for modern, ambitious trade deals. It signals India’s readiness to engage globally, ...

Television star Aly Goni, currently seen in Laughter Chefs Season 2, revealed he and Jasmin Bhasin faced religious ...

Net Sales at Rs 63.64 crore in March 2025 up 29.53% from Rs. 49.13 crore in March 2024. Quarterly Net Profit at Rs. 21.44 ...

CUET UG 2025 will now start from May 13 instead of May 8. NTA has released the city intimation slip on May 7. Know how to ...

Discover the majestic Kori Bustard, the world's heaviest flying bird, found in Africa's open grasslands and savannas, and ...

India's top two exchanges, the National Stock Exchange (NSE) and BSE Ltd, have temporarily restricted access to their ...

In today’s edition of Pro Panorama: A stock with a lasting imprint, leaders of market rally, NBFC warning signs, priority ...

Motilal Oswal reiterated its 'Buy' rating on the stock with a target price of Rs 7,600 per share. This implies an upside potential of nearly 13 percent from the current market price.